Iteos Therapeutics Inc (ITOS) — Cash Flow Quality Index
Iteos Therapeutics Inc (ITOS) has a Cash Flow Quality Index of -1.33x as of December 2022. Operating cash flow of $-27.17 Million is below net income of $20.45 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ITOS operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Iteos Therapeutics Inc Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for Iteos Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Iteos Therapeutics Inc (ITOS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Iteos Therapeutics Inc (2021–2022)
Year-by-year earnings quality comparison for Iteos Therapeutics Inc. For live market cap and the full company financial profile, see Iteos Therapeutics Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.15x | $-111.19 Million | $96.65 Million | ▼ -148.1% |
| 2021 | 2.39x | $513.14 Million | $214.52 Million | — |